GSK3B and Alzheimer disease: As neurodegenerative changes in the brain are often the result of long-lasting or prolonged microglia activation, mitigation of GSK3β activity might be considered a means to limit neuroinflammation and to stave off the effects of age-related diseases, such as AD [100].